Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-04-28, Stock:JNJ, The news for the past five days is as follows:
2020-04-21: NEWS1: U.S. replaces director of agency overseeing COVID-19 vaccines, drugs.
2020-04-22: NEWS1: Hedge Funds’ This Stock Pick Debunked Naysayers.NEWS2: Johnson & Johnson Lifted to Buy as Outperformer in `Difficult Times'.NEWS3: These 'Healthy' Stocks Tip The Coronavirus Market In Your Favor.NEWS4: AbbVie Gets FDA Nod for Imbruvica+Rituxan in First-Line CLL.
2020-04-23: NEWS1: Johnson & Johnson Announces Collaboration to Expand Manufacturing Capabilities For its COVID-19 Vaccine Candidate in Support of the Company's Goal to Supply More Than One Billion Vaccine Doses Globally.NEWS2: 21% tested positive for coronavirus antibodies in NYC, Cuomo says .NEWS3: Johnson & Johnson: Full Recovery in Sight.NEWS4: Is ISRG Stock A Buy After Coronavirus Slammed Quarterly Growth?.NEWS5: The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt.
2020-04-24: NEWS1: Covid Report: How A J&J Vaccine Deal Sent This Biotech Stock Flying.NEWS2: Coronavirus update: Maker of Lysol warns against injecting it and Russia sees major spike in virus cases overnight.NEWS3: Covid Report: How A J&J Vaccine Deal Sent This Biotech Stock Flying.NEWS4: Big Pharma Will Turn to Mergers After Crisis, Says RBC.NEWS5: Covid Report: Biotech Stock Flies On J&J Deal To Make Coronavirus Vaccine.NEWS6: Biotech and Pharmaceutical Stocks Beat the Market in Recessions.NEWS7: Emergent BioSolutions, Johnson & Johnson Sign Virus-Vaccine Accord.NEWS8: J&J to pay Emergent $135 million as part of COVID-19 vaccine manufacturing deal.NEWS9: J&J strikes deal with Emergent BioSolutions on coronavirus vaccine manufacturing.
2020-04-27: NEWS1: Federal Judge Excludes Certain Plaintiff Expert Testimony from Talc Ovarian Cancer Trials, Deeming Them Not Scientifically Sound.NEWS2: U.S. judge rules talc lawsuits against J&J can proceed, testimony limited.NEWS3: CORRECTED-U.S. judge rules talc lawsuits against J&J can proceed, testimony limited.NEWS4: Emergent BioSolutions, J&J join forces for COVID-19 vaccine manufacturing.NEWS5: Big Drug Stock Q1 Earnings Due on Apr 28: MRK, PFE and NVS.NEWS6: JNJ Submits Japan Filing for New Daratumumab Formulation.

Answer: Decrease